Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Gentamicin
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
Amber SPA
Gentamicin
(Eye Drops)
Eye, Antibacterials, 11.03.01
GREEN
Gentamicin 0.3%
(Ear drops )
Ear, nose and oropharynx, Anti-infective preparations, 12.01.01
RED
Gentamicin 20mg/2mL, 80mg/2mL
(Injection)
Infections, Aminoglycosides, 05.01.04
Amber SPA
Gentamicin single use 0.5% Minims
®
Gentamicin Sulphate
Eye, Antibacterials, 11.03.01
GREEN
Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone
®
HC
Ear, nose and oropharynx, Anti-inflammatory preparations, 12.01.01
RED
Cerament G 5mL, 10mL (3rd Generation)
(Bone Void Filler)
Miscellaneous, Medical Devices and other products, 16.01
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Gentamicin
Gentamicin
Anti-Infective, Bacterial Infection, Antibacterials Aminoglycosides
Gentamicin
Gentamicin
Ear, Otitis Externa, Antibacterials Aminoglycosides
Gentamicin
Gentamicin
Eye, Eye Infections, Bacterial Eye Infection, Antibacterials Aminoglycosides
Gentamicin
Gentamicin With Hydrocortisone
Ear, Otitis Externa
Gentamicin
Gentamicin With Hydrocortisone
Ear, Otitis Externa, Antibacterials Aminoglycosides
Links found
MHRA Drug Safety Update (January 2021): Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations